Reduced expression of APC and DCC gene protein in breast cancer

Histopathology

Volumn 35, Issue 3, 1999, Pages 249-256

  Ho, K Y K ^a   Kalle, W H J ^b   Lo, T H S ^c   Lam, W Y ^a   Tang, C M C ^a  

^a TUEN MUN HOSPITAL   (Hong Kong)

^b CHARLES STURT UNIVERSITY   (Australia)

^c Caritas Medical Centre Hong Kong   (Hong Kong)

Author keywords

APC gene; Breast neoplasm; DCC gene; Immunohistochemistry

Indexed keywords

ONCOPROTEIN;

ARTICLE; BREAST CANCER; BREAST TUMOR; CLINICAL ARTICLE; COLON MUCOSA; COLON POLYPOSIS; COLORECTAL CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOMATOUS POLYPOSIS COLI PROTEIN; BREAST; BREAST NEOPLASMS; CELL ADHESION MOLECULES; COLON; COLORECTAL NEOPLASMS; CYTOSKELETAL PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; RECEPTORS, CELL SURFACE; TUMOR SUPPRESSOR PROTEINS;

EID: 0032833946     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1999.00725.x     Document Type: Article

References (36)

1. Dixon JM, eds. ABC of Breast Diseases, London: BMJ. 1995.
2. World Health Organization (WHO). The world health report 1997 (cited 1997 Sep 25). Available from: URL.: http://www.who.ch/whr/1997/factse.html
3. Unit of Descriptive Epidemiology (DEP). GLOBOcan (cited 1997 November 4). Available from: URL: http://www-dep.iarc.fr/egi-bin/cgisq1/year2.idc.
4. World Health Organization (WHO). WHO Databank (cited 1997 November 4). Available from: URL: http://www-dep.iarc.fr/cgi-bin/cgisq1/who2.idc.
5. Ross DW. Cancer. Introduction to Molecular Medicine. 2nd edn. New York: Springer-Verlag, 1996; 129-161.
6. Fearon ER, Vogelstein B. A somatic model of colorectal tumorigensis. Cell 1990; 6; 759-767.
7. Sjodahl R, Nystrom PO. Genetic aspects of colorectal canccr: the surgeon's view. Scand. J. Gastroenterol. 1996; 31 (Suppl. 220); 132-136.
8. Strachan T, Read AP. Somatic mutation and cancer. In Human Molecular Genetics. Oxford: BIOS Scientifc, 1996, 457-477.
9. Garrett CT, Liscia DS, Nasim S, Ferreira-Gonzalez A. Genetics of colorectal and breast cancer. Clin. Lab. Med. 1995; 15; 957-971.
10. Hoops TC, Traber PG. Molecular pathogenesis of colorectal cancer. Haemetol. Oncol. Clin. N. Am. 1997; 11; 609-633.
11. Smith KJ, Johnson KA, Bryan TM et al. The APC gene product in normal and tumour cells. Proc. Natl. Acad. Sci. USA 1993; 90; 2846-2850.
12. Midglay CA, White S, Howitt R et al. APC expression in normal human tissues. J. Pathol. 1997; 181; 426-433.
13. Fearon ER, Ekstrand BC, Hu G, Pierceall WE Reale MA, Binger SH. Studies of the deleted in colorectal cancer gene in normal and neoplastic tissues. Cold Spring Harbour Symposium. Quant. Biol. 1994; 59; 637-643.
14. Fearon ER. DCC: Is there a connection between tumorigenesis and cell guidance molecules? Biochim. Biophys. Acta. 1996; 1288; M17-M23.
15. Enomoto T, Fujita M, Cheng C et al. Loss of expression and loss of heterozygosity in the DCC gene in neoplasms of the human female reproductive tract. Br. J. Cancer 1995; 71; 462-467.
16. Porfiri E, Secker-Walker LM, Hoffbrand AV, Hancock JF. DCC tumour suppressor gene is inactivated in haematologic malignancies showing monosomy 18. Blood 1993; 81; 2696-2701.
17. Sellner LN, Turbett GR. Detection of gene mutations using the protein truncation test. Adv. Anatom. Pathol. 1997; 4; 123-133.
18. Akehi S, Murao S, Ueda N et al. Immunohistochemical detection of truncated APC protein in sporadic human colorectal adenomas and adenocarcinomas. Virchows Arch. 1996; 429; 21-26.
19. Chop AM, Abraham CL, Adrian TE, Murphy R, Boman BM. Immunodetection of the presence or absence of full-length APC gene product in human colonic tissues. Anticancer Res. 1995; 15; 991-997.
20. Shibata D, Reale MA, Lavin P et al. The DCC protein and prognosis in colorectal cancer. New Eng. J. Med. 1996; 335; 1727-1732.
21. Dako. A Guide to Demasking of Antigen on Formalin-Fixed, Paraffin-Embedded Tissue. Denmark: Dako, 1997.
22. Shi S, Cote RJ, Young LL, Taylor CR. Antigen retrieval immuno-histochemistry: practice and development. J. Histotech. 1997; 20; 145-154.
23. Miyoshi Y, Ando H, Nagase H et al. Germ-line mututions of the APC gene in 53 familial adenomatous polyposis. Proc. Natl. Acad. Sci. USA 1992; 89; 4452-4456.
24. Iino H, Fukayama M, Maeda Y et al. Molecular genetics for clinical management of colorectal carcinoma. 17p. 18q and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential. Cancer 1994; 71; 1324-1331.
25. Horstmann MA, Pösl M, Schloz RB et al. Frequent reduction or loss of DCC gene expression in human osteosarcoma. Br. J. Cancer 1997; 75; 1309-1317.
26. Kashiwaba M, Tamura G, Ishida M. Frequent loss of heterozygosity at the deleted in colorectal carcinoma gene locus and its association with histologic phenotypes in breast carcinoma. Virchows Arch. 1995; 426; 441-446.
27. Thompson AM, Morris RG, Wallace M, Wyllie AH, Steel CM, Carter DC. Allele loss from 5q21 (APC/MCC) and 18q2l (DCC) and DCC mRNA expression in breast cancer. Br. J. Cancer 1993; 68; 64-68.
28. Devilee P, var-Vliet M, Kuipers-Dijkshoom N, Pearson PL, Cornelisse CJ. Somatic genetic changes on chromosome 18 in breast carcinoma: is the DCC gene involved. Oncogene 1991; 6; 311-315.
29. Wakita K, Kohno N, Sakoda Y, Ishikawa Y, Sakaue M. Decreased expression of the DCC gene in human breast carcinoma. Surg. Today 1996; 26; 900-903.
30. Elstun CW. The assessment of histological grade in breast cancer. Aust. N. Z. J. Surg. 1984; 54; 11-15.
31. Elston CW, Gresham GA, Rao GS et al. The cancer research campaign (Kings/Cambridge) trial for early breast cancer - pathological aspects. Br. J. Cancer 1982; 45; 655-669.
32. Fang D-C, Jass Jr. Wang D-X. Loss of heterozygosity and loss of expression of the DCC gene in gastric cancer. J. Clin. Pathol. 1998; 51; 593-596.
33. Wada M, Miller CW, Yokota J, Lee E, Mizoguchi H, Koeffler HP. Molecular analysis of the adenomatous polyposis coli gene in sarcomas, haematological malignancies and noncolonic, neo-plastic tissues. J. Mol. Med. 1997; 75; 139-144.
34. Powell SM. Familial polyposis syndromes advances in molecular genetic characterization. Surg. Oncol. Clin. N. Am. 1996; 5; 569-587.
35. Wong MH, Hermiston ML, Syder AJ, Cordon JL. Forced expression of the tumour suppressor adenomatous polyposis coli protein induces disordered cell migration in the intestinal epithelium. Proc. Natl. Acad. Sci. USA 1996; 93; 1073-1077.
36. Rubinfeld B, Souza B, Albert I et al. Association of the APC gene product with β-catenin. Science 1993; 262; 1731-1737.